Podcasts about Neurostimulation

In this enlightening episode of the Harvest Series, Rose Claverie speaks with Professor Bruno Ribeiro do Couto, a cognitive health expert, about how we can optimize our brains for longevity. Professor Ribeiro shares his expertise on the connection between exercise, diet, and mental well-being. He also delves into how advanced technology and neurostimulation are helping us preserve brain function as we age. Join us as we explore the future of brain health and cognitive enhancement.Harvest and SHA are joining forces in Kaplankaya for season 9, with top scientists coming all the way to Türkiye. And Professor Ribeiro will be one of them!Chapters : 00:00 - Introduction 01:00 - Cognitive health and its impact on longevity 03:00 - The power of exercise for the brain 06:00 - Brain-boosting foods and their role in longevity 09:00 - Managing stress and its effect on the brain 12:00 - Neurostimulation and its impact on mental health 16:00 - The role of AI and personalized care in brain health 20:00 - Conclusion: Taking action to protect your brain24:24 - What is our brain going to be able to do in the Future?29:00 - How to protect children's brains?You can follow us on Instagram at @HarvestSeries or @rose.claverie for updates.Watch our podcast episodes and speaker sessions on YouTube: Harvest Series.Credits:Sound editing by: @lesbellesfrequencesTechnician in Kaplankaya: Joel MoriasiMusic by: ChambordArtwork by: Davide d'AntonioHarvest Series is produced in partnership with Athena Advisers and Capital PartnersHarvest Series Founders: Burak Öymen and Roman Carel

Kirk Huntsman, CEO of Vivos Therapeutics, a pioneer in the treatment of obstructive sleep apnea. With decades of experience in the dental and medtech space, Kirk has led Vivos to secure multiple FDA clearances including the first ever for treating moderate to severe pediatric sleep apnea using an oral applianceIn this episode, we uncover why sleep apnea is a silent global epidemic, why it's so underdiagnosed and how Vivos is transforming the way we approach treatment, shifting from CPAP-based management to true rehabilitation. Kirk also shares how Vivos is achieving life-changing results in less than a year, and why even mild, untreated sleep apnea can lead to serious downstream health issues like hypertension, depression and cognitive decline. We also discuss societal misperceptions, global prevalence and exciting innovations that could one day lead to a cureTimestamps:[00:00:27] What Is Obstructive Sleep Apnea and Why It's Dangerous[00:03:07] Why Sleep Apnea Remains Widely Undiagnosed[00:06:49] Changing the Narrative Around Snoring and Awareness[00:08:49] FDA Breakthroughs: Treating Children and Adults Differently[00:13:13] CPAP vs Vivos: Why Patients Need a Third Option[00:17:26] From Dentistry to MedTech: The Journey to Founding Vivos[00:26:07] The Future of Sleep Medicine and Ending Apnea PermanentlyGet in touch with Kirk - https://www.linkedin.com/in/kirkhuntsman Get in touch with Karandeep Badwal - https://www.linkedin.com/in/karandeepbadwal/ Follow Karandeep on YouTube - https://www.youtube.com/@KarandeepBadwalSubscribe to the Podcast

Rund vier Millionen Deutsche leiden laut Weltgesundheitsorganisation WHO an Depressionen, die Dunkelziffer ist hoch. Meist wird die Erkrankung mit Psychotherapie und/oder Psychopharmaka behandelt. „Ein bisschen in Vergessenheit geraten, sind darüber leider die Verfahren der sogenannten Neurostimulation“, sagt Dr. Jan Alexander Schwesinger, Oberarzt für Akutpsychiatrie und Psychosen an der Asklepios Klinik Nord-Ochsenzoll. Dort leitet er das vor rund einem Jahr neu gegründete Zentrum für Neurostimulation. Was genau dort passiert und wie es den Patienten hilft, erklärt der Mediziner in dieser Folge.

Can technology transform the way we approach health and healing? In this episode, we explore the intersection of neuroscience, innovation, and the mind-body connection with Dr. Brennan Spiegel from Cedars-Sinai. Dr. Spiegel challenges the long-standing myth that the mind and body function separately, revealing how our thoughts, emotions, and physiological responses are deeply intertwined.We take a deep dive into alternative therapies that go beyond conventional treatments, including vagus nerve stimulation (VNS) and its impact on relaxation, well-being, and potential applications in treating health conditions. From implanted devices to non-invasive, direct-to-consumer options, we break down how VNS works and its role in the parasympathetic nervous system (think: rest and digest). We also discuss percutaneous electrical nerve field stimulation (PENFS), a distinct yet related therapy offering new opportunities for managing gastrointestinal disorders.But the innovation doesn't stop there. We explore the growing role of virtual reality (VR) in healthcare, examining its influence on physiology, pain management, and patient outcomes. Backed by research from leading institutions like Cedars-Sinai and the Mayo Clinic, we uncover how VR is shaping modern medicine. Also, Dr. Spiegel shares fascinating insights on how gravity affects the body and how cutting-edge technology provides immersive healing experiences for patients in need. Join us as we navigate this exciting frontier where technology and health converge, offering fresh perspectives on how VNS, VR, and the power of the mind-body connection may revolutionize medicine.Tune in now and discover how these advancements could change the future of healthcare and well-being. This podcast episode is sponsored by Ardelyx.References:Vagus Nerve StimulationTherapeutic Efficacy of Neurostimulation for Depression: Techniques, Current Modalities, and Future ChallengesNeurostimulation for abdominal pain-related functional gastrointestinal disorders in adolescents: a randomized, double-blind, sham-controlled trialResources mentioned by Dr. Brennan Spiegelwww.virtualmedicine.orgSynerGI - IBS VR Program available through research studiesXaia - VR support program available through Apple Vision ProTripp VR - Immersive meditation program on mobile and VR devices Vagustim - Vagus nerve stimulation product mentioned by Dr. SpiegelLearn more about Kate and Dr. Riehl:Website: www.katescarlata.com and www.drriehl.comInstagram: @katescarlata @drriehl and @theguthealthpodcastOrder Kate and Dr. Riehl's book, Mind Your Gut: The Science-Based, Whole-body Guide to Living Well with IBS. The information included in this podcast is not a substitute for professional medical advice, examination, diagnosis or treatment. Always seek the advice of your physician or other qualified health care provider before starting any new treatment or making changes to existing treatment.

Welcome to the NeurologyLive® Mind Moments® podcast. Tune in to hear leaders in neurology sound off on topics that impact your clinical practice. In this episode, epilepsy expert Depobam Samanta, MD, MS, FAAP, FAES, sat down to discuss a recently published guidance paper from members of the Pediatric Epilepsy Research Consortium that provides recommendations for neuromodulation approaches to treat Lennox-Gastaut syndrome (LGS). Samanta, medical director of the Arkansas Children's Comprehensive Epilepsy Program, gave a clinical overview of the paper, highlighting the various neuromodulatory devices and their use, and the ways to improve treatment selection and personalization. Additionally, he talked about some of the potential complications with these devices as well as initiation and titration strategies for easy initiation. Furthermore, he spoke about ways to take neuromodulation to the next level, giving insight on creative trial designs, overcoming sham-controlled studies, and the necessary research to expand these approaches.  Looking for more epilepsy discussion? Check out the NeurologyLive® Epilepsy clinical focus page. Episode Breakdown: 1:05 – Overview of the published guidance and reasons behind the paper  5:15 – Patient selection for neuromodulation and tailoring treatments by patient and preference 8:25 – Overcoming complications with neuromodulation devices  11:25 – Multidisciplinary team necessary for successful implementation of neuromodulation 13:15 – Neurology News Minute 15:15 – Initiation and titration strategies for vagus nerve stimulation, deep brain stimulation, and resective surgery 18:30 – Next steps in research and expanding neuromodulation for patients with LGS 21:10 – Finding creative trial designs to test neuromodulation devices, combination approaches The stories featured in this week's Neurology News Minute, which will give you quick updates on the following developments in neurology, are further detailed here: FDA Accepts BLA for Subcutaneous Autoinjector Formulation of Lecanemab Cell Therapy Bemdaneprocel Advances to Phases 3 Registrational Trial in Parkinson Disease Real-World Study Highlights Positive Treatment Benefits of Tofersen on ALS Disease Progression, Function Thanks for listening to the NeurologyLive® Mind Moments® podcast. To support the show, be sure to rate, review, and subscribe wherever you listen to podcasts. For more neurology news and expert-driven content, visit neurologylive.com.

Kate Willis is an esteemed leader in Healthcare and MedTech, known for her strategic prowess and innovative approaches. Currently, she serves as the Vice President of Commercialization at Neurovalens, responsible for leading all global and US commercial functions, including the US launch. Her career highlights include serving as the Director of Government Affairs and Advocacy, where she has been a powerful force in shaping industry standards and policies.Kate's robust track record of leadership extends through premier companies such as Nevro, Medtronic, Nuvasive, and Zimmer Biomet, where her initiatives have not only spurred organizational growth but have also earned her multiple accolades. These honors include prestigious recognitions such as multiple President's Club awards, Sales Rep of the Year, and Rookie of the Year. Beyond her healthcare expertise, Kate is a recognized figure in the arts as a producer and investor, with successful ventures in Broadway, West End, and film productions. Her unique flair for bridging the realms of business and entertainment underlines her diverse capabilities and visionary outlook. SHOWNOTES:

Have you heard of temporal interference (TI) electrical stimulation, a revolutionary concept of non-invasive deep brain stimulation (DBS)? Curious about what it takes to develop cutting-edge neuromodulation techniques while pursuing a scientific career across two continents? Welcome to the Women in Neurotech series on the Neurocareers: Doing the Impossible! podcast!

Moderator: Bernhard J. Steinhoff (Kehl-Kork, Germany)Guest: Kristl Vonck (Gent, Belgium)In this episode, Bernhard Steinhoff speaks with expert Kristl Vonck on the latest advancements in neurostimulation therapies for epilepsy. They explore how innovations in vagus nerve and deep brain stimulation are enhancing personalized treatment approaches, offering new hope for epilepsy patients resistant to traditional therapies.

As the surgeon general has stated, we are in a mental health crisis. Depression is the leading cause of disability worldwide. And a major challenge is that depression can be difficult to treat, especially for people who don't respond well to talk therapy or antidepressants.But there's a relatively new technique that seems to have a significant positive impact on people with treatment-resistant depression, even sending many of them into remission. It's called transcranial magnetic stimulation (TMS) and it uses magnets to stimulate certain areas of the brain that play a role in depression.A team at Stanford developed a protocol for TMS that received FDA clearance in 2022 and, as of this year, it's covered by Medicare. In a study from 2021, it was shown to improve remission rates for depression by up to 80%, with one patient calling it “a game changer.”So how does TMS work, and could it change the way we treat depression and other mental illnesses?Ira Flatow is joined by Dr. Nolan Williams, associate professor of psychiatry and behavioral sciences at Stanford University, where he's also the director of the Stanford Brain Stimulation Lab. They talk about the advances that Williams' team made with their SAINT protocol (Stanford Accelerated Intelligent Neuromodulation Therapy), patient experiences with the technology, and potential future applications of this technique.Transcripts for each segment will be available after the show airs on sciencefriday.com. Subscribe to this podcast. Plus, to stay updated on all things science, sign up for Science Friday's newsletters.

Chronic low back pain is a complex condition often caused by multiple factors, making accurate diagnosis and treatment challenging. In this episode, Kristen Klein, a certified nurse practitioner at the New York Spine and Pain Specialists in Port Jefferson, New York, discusses innovative approaches to diagnosing and treating chronic low back pain, particularly focusing on multifidus dysfunction. She highlights the importance of understanding pain contributors, the value of MRIs for tracking muscle deterioration, and the benefits of restorative neurostimulation, a therapy that addresses the root cause of pain. Kristen explores the role of technology and education in improving patient outcomes and reducing healthcare costs and stresses the significance of setting personal goals for patients, which enhances their motivation and measures the success of treatments. She also provides advice for healthcare providers on incorporating this therapy into their practices and underscores the importance of team involvement for seamless patient care. Tune in to learn about the latest advancements in chronic pain management, which could transform your practice and patient outcomes! Resources:  Watch the entire episode here. Connect with and follow Kristen Klein on LinkedIn.  Learn more about Mainstay Medical on LinkedIn and their website. Listen to the other episodes of our Mainstay Medical series.

Viele von euch werden wahrscheinlich an Gesprächstherapie oder Medikamente wie Anti-Depressiva zur Behandlung psychischer Erkrankungen denken. Dabei gibt es mit der Neurostimulation noch einen ganz eigenen und besonderen Bereich in der medizinischen Behandlung psychischer Erkrankungen, den wir bei uns seit kurzem in unserem Neurostimulationszentrum unter Leitung von Prof. Dr. Dr. Sprick anbieten. Unser Oberarzt Dr. York Christoph Vogel ist buchstäblich seit seinen Kindertagen fasziniert von Physik, Strom und seinen vielfältigen Möglichkeiten: In dieser Podcast-Folge lernt ihr nicht nur ihn ganz persönlich kennen, sondern darüber hinaus erfahrt ihr, was es mit EKT (Elektrokonvulsionstherapie), rTMS (repetitiver transkranieller Magnetstimulation) und der TPS (Transkranielle Pulsstimulation) auf sich hat, wie sie funktionieren, was es dabei zu beachten gilt und wie die Behandlungsverfahren bei diversen psychischen Erkrankungen und sogar Alzheimer Demenz (hier kommt die TPS zum Einsatz) erfolgreich helfen können. Übrigens: Ihr lernt in dieser Folge auch, dass die von uns im Neurostimulationszentrum angewendeten Verfahren absolut nichts mit den destruktiven Verfahren zu tun haben, die einige von euch aus Hollywood-Filmen wie "Einer flog über das Kuckucksnest" - vielmehr sind sämtliche Verfahren extrem nebenwirkungsarm. Viel Spaß beim Hören und wie immer freuen wir uns über Eure Kommentare und Fragen zum Thema! Ihr wollt uns Feedback geben?Dann schreibt uns einfach an podcast-ajk@ak-neuss.de Wir freuen uns auf eure Anregungen und Kommentare!

In this episode of the One Thing podcast, Dr. Peter discusses the profound impact of her father's experiences as a Holocaust survivor on her life and career as a trauma psychologist. The conversation delves into the effects of generational trauma, the physiological and psychological responses to significant traumatic events, and the steps taken to aid survivors of the recent October 7th attacks in Israel. Dr. Peter highlights her work with the Israel Healing Initiative, emphasizing the importance of neurostimulation in trauma treatment and her ongoing efforts to provide support across affected communities, including Jewish, Palestinian, Bedouin, and Druze populations. The discussion includes poignant survivor stories and touches upon the broader implications of trauma within a global context. The conversation highlights, stories of heroism during October 7, the importance of social support, the difference between real trauma and perceived trauma, and the need for practical solutions to promote post-traumatic growth. The episode provides invaluable knowledge on trauma response, the use of vagal nerve stimulation, neurostimulation, and ways to support continued efforts in mitigating trauma's impact on both Israeli and Palestinian communities. Here are some of the topics we cover: Father's Journey and Influence 9/11 and Global Reactions Understanding Trauma and PTSD October 7th Events and Initial Reactions Personal Stories of Survival Neurostimulation and Trauma Treatment Scaling Up Nonprofit Efforts Treating Trauma with Vagus Nerve Stimulators Personal Stories of Trauma and Healing Understanding the Physical Impact of Trauma The Role of Neurostimulation in Post-Traumatic Growth Supporting the Israel Healing Initiative About Dr. Peter: As the daughter of a Holocaust survivor, Dr. Peter has devoted her three-decade career to providing specialized treatment to survivors worldwide. Her experience spans diverse communities, including Iranian refugees, residents of the Qalandia refugee camp, and individuals from Arab, Druze, and Jewish Israeli backgrounds in the aftermath of the war. She has also provided support to witnesses of the 9/11 attacks. Previously holding the role of associate professor of psychology at Mount St. Mary's University in Los Angeles, Dr. Peter oversaw the Psychology Graduate Programs and served as acting Chair of the Psychology Department. Dr. Peter's academic journey culminated in a Ph.D. from the University of California at Berkeley, followed by three postdoctoral fellowships in clinical psychology, social psychology, and neuropsychology. Her dedication led to diplomate status in Clinical Psychology from the American Board of Psychological Specialties. Her expertise is deepened by her studies with pioneers in the field of Interpersonal Neurobiology, such as UCLA professors Allan Schore and Dan Siegel. This expertise allows her to effectively apply these principles in helping traumatized individuals regulate their emotions. Her certification in Homeland Security by the American Board of Psychological Specialties speaks to her expertise in trauma-related research and treatment. Her consultancy with the RAND Corporation on terrorism research demonstrates her commitment to understanding and addressing the psychological impact of traumatic events. Dr. Peter is the Vice President of Free Hearts Free Minds, an organization that provides trauma counseling and support to free-thinking ex-Muslims who have faced or are at risk of persecution from their families or communities. Socials Israel Healing Initiative Facebook Page Instagram --- Support this podcast: https://podcasters.spotify.com/pod/show/onethingpod/support

Internationally renowned bipolar disorder expert Dr. Trisha Suppes unravels the latest science in bipolar disorder treatment by breaking down the proven and cutting-edge treatments available today - exploring traditional solutions such as Lithium and mood stabilizers alongside exciting new options like psilocybin, ketamine, and the Ketogenic diet. Dr. Suppes also navigates the complexities of mania and tackles the perennial question: is lifelong medication necessary to live well with bipolar disorder? (00:00) About Dr. Suppes Medication Treatments (03:00) Is Lithium the Gold Standard? (05:22) Atypical Antipsychotics (07:22) Dangers of Antidepressants? (09:17) Medications Lose Strength? Non-medication Treatments (10:47) Psychotherapy (12:54) Ketogenic Diet & Nutrition (13:28) Cannabis (14:20) Ketamine Brain Stimulation Therapies (15:18) rTMS (Transcranial Magnetic Stimulation) (16:01) VNS (Vagus Nerve Stimulation) (17:07) ECT (Electroconvulsive Therapy) Bipolar Disorder is Complex (18:52) Insight & Denying Bipolar Disorder (22:45) Bipolar I: Need Meds Forever? (23:44) Bipolar II: Need Meds Forever? (26:22) Hypomania Causes Misdiagnosis (28:16) Mixed States Psychedelics (29:28) Psilocybin & Magic Mushrooms (32:33) Microdosing & LSD (34:02) MDMA Closing (35:41) Keeping You "A Little Depressed" (37:55) Why Recovery Is Possible (39:06) Reflecting on Research Impact Dr. Trisha Suppes, M.D., Ph.D., is a distinguished expert on the biology and treatment of bipolar disorder, and mood disorders generally. Dr. Suppes is the Director of Exploratory Therapeutics and Professor at Stanford University in the School of Medicine. At the VA Palo Alto Health Care System, she is Director of the CSP NODES and is the Founder of the Bipolar and Depression Research Program. Her areas of expertise include long-term treatment strategies for bipolar disorder, identification and treatment of bipolar II disorder, treatment of those with bipolar disorders and co-morbid conditions and use of complementary medicine. She has recently launched a new initiative to explore the use of psychedelics for mood disorders and PTSD in Veterans. Dr. Suppes has been integrally involved in numerous initiatives to improve evidence-based treatment for bipolar disorders. Dr. Suppes participated as a member of the DSM-5 Mood Disorders committee on updating the APA DSM-5 criteria for Mood Disorders and was chair of the APA DSM-5 Bipolar Disorder subcommittee. She was the past President of the International Society of Bipolar Disorders (ISBD). Treatments Referenced

Der Neurochirurg Daniel Martin behandelt mit Nervenstimulation vor allem Patienten mit chronischen Knieschmerzen. Er schaltet mithilfe einer dünnen Elektrode den Schmerz gezielt aus. Ein Test ermittelt vorher die Erfolgsaussichten.

New steroid-free topical for atopic dermatitis; A refillable ocular implant for the treatment of  neovascular (wet) age-related macular degeneration returns following recall; A neuroimmune modulation device shows clinical benefit in adults with rheumatoid arthritis; FDA denies Novo Nordisk's once-weekly insulin icodec; And a smarthphone therapy shows benefit for patients with fibromyalgia.

“As far as medical treatments go, ECT is the safest medical procedure in all of medicine.”Will the stigma around ECT fade? Will ECT simply grow less relevant in the age of ketamine and MST? What's the future of neuromodulation?Join Dr. David Gratzer as he speaks to Dr. Daniel Blumberger, scientific director of the Temerty Centre for Therapeutic Brain Intervention and professor at the University of Toronto to find out.During their discussion, we learn about:the 20-30 active clinical trials at the Temerty Centrethe impact and efficacy of some of the newer treatments like ketamine, rTMS, and MSTthe latest in the literature on ECT and suicide preventionand that ECT isn't being replaced any time soon. THANKS FOR LISTENING!Quick Takes is a production of the Center for Addiction and Mental Health. You can find links to the relevant content mentioned in the show and accessible transcripts of all the episodes we produce online at CAMH.ca.Follow CAMH Education on X (formerly known as Twitter) @camhEduFollow and subscribe to Reading of the Week where, every week, Dr. David Gratzer reviews research papers from the world of psychiatry.

Summary Today, we are thrilled to have Dr. Erik Won, President and CEO of Wave Neuroscience, with us. Dr. Won and his team are at the forefront of revolutionizing mental health and cognitive performance through innovative technology. Wave Neuroscience offers a groundbreaking treatment known as magnetic EEG-guided resonance therapy, designed to help veterans, athletes, and individuals struggling with mental health conditions. This personalized treatment involves three key steps: measuring brain activity with an EEG, using computational neuroanalytics to identify disruptions, and applying gentle transcranial magnetic stimulation (TMS) to restore optimal brain function. The results have been remarkable, with significant improvements in cognitive function, sleep quality, and overall well-being. In our conversation today, Dr. Won will shed light on how Wave Neuroscience is pushing the boundaries and touch on other mental health topics like psychedelic assisted therapy, autism, PTSD, traumatic brain injury, COVID-19 brain fog, and substance use disorders. Join us as we explore the cutting-edge world of neuroscience technology and its potential to transform lives, offering hope and long-term solutions for those battling brain injuries and mental health issues. Show Links Get 1-month of FREE access to the ⁠Vet Collective Community⁠ by using discount code: NLT1UQTI Join us here: ⁠⁠⁠https://www.collective.vet⁠⁠⁠ Sign up for our Weekly Newsletter: ⁠⁠⁠⁠https://www.collective.vet⁠⁠⁠ Follow us on LinkedIn: ⁠ ⁠https://www.linkedin.com/company/harder-not-smarter/⁠ Episodes also available on Spotify, Apple, and Amazon Music. https://linktr.ee/harder_not_smarter Erik's Links https://www.linkedin.com/in/erik-won-86941614/ https://waveneuro.com https://www.instagram.com/waveneuro/ https://www.facebook.com/WaveNeuro Chapters 00:00 Introduction and Background 03:22 Overview of Treatment and Mission 08:32 Expanding Beyond Special Operations Veterans 11:42 The Importance of Sleep and Long-Term Health 25:11 Combining Modalities and Future Research 28:34 Differentiating from Neurofeedback 31:00 The Trifecta Study 33:41 Different Treatment Options 34:25 Personalized Treatment for Mental Health and Addiction 39:51 Treatment for Autism 44:12 Diagnosis and Treatment for Autism 46:38 Treatment Protocol for Children with Autism 48:21 Duration and Long-Term Benefits of Treatment 52:21 Importance of Environment and Lifestyle in Treatment 53:32 Expansion of Treatment and Support Programs 56:26 Controversies and Recommendations on Supplements 01:01:01 Future Research and Trials 01:04:29 Availability of Wave Neuro Treatment Takeaways Wave Neuroscience offers magnetic EEG guided resonance therapy to help veterans and athletes with mental health conditions and cognitive performance. The treatment involves three steps: EEG to measure brain activity, computational neuroanalytics to identify disruptions, and TMS to provide gentle stimulation and restore brain networks. The treatment has shown significant improvements in cognitive function, sleep quality, and overall well-being. Wave Neuroscience is involved in a study combining hormone replacement therapy, psychedelic therapy, and TMS to explore the potential synergistic effects of these modalities. Wave Neuroscience offers personalized treatment for mental health conditions and addiction using neurostimulation. Neurostimulation has shown positive results in improving behavior and cognitive function in autism. The diagnosis of autism typically occurs in children between 18 months and 4 years old. The duration and long-term benefits of treatment depend on the individual's lifestyle and self-care practices. The environment and lifestyle play a significant role in the success of treatment. Wave Neuroscience is actively involved in FDA trials for PTSD, traumatic brain injury, COVID-19 brain fog, and substance use disorder.

MedLink Neurology Podcast is delighted to feature selected episodes from BrainWaves, courtesy of James E Siegler MD, its originator and host. BrainWaves is an academic audio podcast whose mission is to educate medical providers through clinical cases and topical reviews in neurology, medicine, and the humanities, and episodes originally aired from 2016 to 2021. Originally released: November 13, 2017 How often do you call the plumber and say, "My faucet is leaking," and then the plumber REMOVES your faucet? Problem solved, right? Ironically, this simplistic approach works extremely well in a variety of epileptic conditions. In this week's show, Dr. Myriam Abdennadher and Danielle Becker comment on the protocol and efficacy for surgery in patients with drug-resistant epilepsy. Produced by James E. Siegler. Music by Little Glass Men, Montplaisir, Three Chain Links, and Squire Tuck. Voiceover by Isa Smrstik. BrainWaves' podcasts and online content are intended for medical education only and should not be used for clinical decision-making. REFERENCESDeGiorgio CM, Krahl SE. Neurostimulation for drug-resistant epilepsy. Continuum (Minneap Minn) 2013;19(3 Epilepsy):743-55. PMID 23739108Engel J Jr, Wiebe S, French J, et al. Practice parameter: temporal lobe and localized neocortical resections for epilepsy: report of the Quality Standards Subcommittee of the American Academy of Neurology, in association with the American Epilepsy Society and the American Association of Neurological Surgeons. Neurology 2003;60(4):538-47. Erratum in: Neurology 2003;60(8):1396. PMID 12601090Englot DJ, Wang DD, Rolston JD, Shih TT, Chang EF. Rates and predictors of long-term seizure freedom after frontal lobe epilepsy surgery: a systematic review and meta-analysis. J Neurosurg 2012;116(5):1042-8. PMID 22304450Jobst BC, Cascino GD. Resective epilepsy surgery for drug-resistant focal epilepsy: a review. JAMA 2015;313(3):285-93. PMID 25602999Schwartz TH, Spencer DD. Strategies for reoperation after comprehensive epilepsy surgery. J Neurosurg 2001;95(4):615-23. PMID 11596956Spencer S, Huh L. Outcomes of epilepsy surgery in adults and children. Lancet Neurol 2008;7(6):525-37. PMID 18485316 We believe that the principles expressed or implied in the podcast remain valid, but certain details may be superseded by evolving knowledge since the episode's original release date.

What does it take to successfully navigate a career in the ever-evolving landscape of neurotechnologies? What is adaptive deep brain stimulation (DBS), and how is it transforming the lives of those with movement disorders? Today, on "Neurocareers: Doing the Impossible!" we dive into these questions with Dr. Stephanie Cernera, DBS research and development specialist, particularly for Parkinson's disease. Dr. Cernera, with her rich background in Biomedical Engineering from Purdue University and a PhD from the University of Florida, has been at the forefront of pioneering DBS strategies. Her groundbreaking work on closed-loop DBS, utilizing wearable sensors for essential tremor patients, has set new standards in the field. Currently, at the prestigious Starr Lab at UCSF, she develops adaptive DBS protocols that leverage local field potentials for more tailored and responsive treatments for Parkinson's disease and dystonia sufferers. Moreover, Stephanie is making a bold career shift by joining Syhchron - a leader in the neurotech industry. In this episode, Dr. Cernera shares her personal career journey through the realm of neurotech. She offers valuable insights on navigating graduate school and postdoctoral applications and discusses the courage it takes to transition from academia to industry. Her story is not just one of scientific innovation but also of personal resilience and the drive to make a significant impact. Dr. Cernera emphasizes the critical importance of teamwork and effective collaboration in today's research environment. As projects expand in complexity, particularly with the vast amounts of data being collected and the intricate questions needing answers, the ability to work harmoniously within a team becomes indispensable. She points out that a well-coordinated team can offer invaluable feedback on data analyses and methodologies, playing a pivotal role in ensuring the success of developed approaches. Dr. Cernera's insights underline the significance of fostering strong team dynamics and the impact of collaborative effort on achieving breakthrough outcomes in neurotech research. Join us as Dr. Cernera delves into her own neurocareer journey from academic DBS research to her pivotal role at Synchron and shares her expert advice for those looking to forge their own paths in this dynamic field. This episode is a must-listen for anyone intrigued by the nexus of technology, healthcare, and neurotech research, promising to inspire and guide future leaders in neurotech. Tune in to uncover the narrative of a neurocareer that has crossed fields, from the academic study of DBS to the cutting-edge industry work at Synchron, with Dr. Stephanie Cernera. About the Podcast Guest: Stephanie is currently a Postdoctoral Fellow at Starr Lab, Department of Neurological Surgery, University of California, San Francisco and she is currently transitioning to her new role in the neurotech industry at Synchron. All the adaptive work Stephanie has been doing in Dr. Starr's lab has been a massive team effort, and there are two co-first authors on the paper besides Dr. Stephanie Cernera. These are Dr. Carina Oehrn and Dr. Lauren Hammer. The preprint of the paper is available here: https://www.medrxiv.org/content/10.1101/2023.08.03.23293450v1 Stephanie encourages anyone to reach out if they have career questions or research questions - she'd be happy to chat! If you are interested in connecting on LinkedIn - Stephanie's profile is https://www.linkedin.com/in/stephanie-cernera-phd-0a438194/ Stephanie's e-mail is stephcernera@gmail.com  Recommended resources from Stephanie: Python on Coursera: https://www.coursera.org/search?query=python Amazon books: https://www.amazon.com/Neural-Data-Science-MATLAB%C2%AE-PythonTM/dp/0128040432 https://www.amazon.com/MATLAB-Neuroscientists-Introduction-Scientific-Computing/dp/0123838363/ref=pd_lpo_3?pd_rd_i=0123838363&psc=1 https://www.amazon.com/MATLAB-Brain-Cognitive-Scientists-Press/dp/0262035820/ref=pd_[…]8b0679b4-6608-4773-94a5-4e68366fbaed&pd_rd_i=0262035820&psc=1   Dr. Cernera also provided several documents that can be helpful for your graduate school and postdoctoral studies applications. The links to these documents will be provided here later. About the Podcast Host: The Neurocareers podcast is brought to you by The Institute of Neuroapproaches (https://www.neuroapproaches.org/) and its founder, Milena Korostenskaja, Ph.D. (Dr. K), a neuroscience educator, research consultant, and career coach for people in neuroscience and neurotechnologies. As a professional coach with a background in the field, Dr. K understands the unique challenges and opportunities job applicants face in this field and can provide personalized coaching and support to help you succeed. Here's what you'll get with one-on-one coaching sessions from Dr. K: Identification and pursuit of career goals Guidance on job search strategies, resume and cover letter development, and interview preparation Access to a network of professionals in the field of neuroscience and neurotechnologies Ongoing support and guidance to help you stay on track and achieve your goals You can always schedule a free neurocareer consultation/coaching session with Dr. K at https://neuroapproaches.as.me/free-neurocareer-consultation Subscribe to our Nerocareers Newsletter to stay on top of all our cool neurocareers news at updates https://www.neuroapproaches.org/neurocareers-news

A groundbreaking restorative neurostimulation therapy for chronic mechanical low back pain is addressing its root cause and providing significant relief. In this episode, Simon Thomson, founder of Pain and Neuromodulation Consulting Ltd, shares insights on the groundbreaking work he's doing for chronic mechanical low back pain. He explains how ReActiv8 involves a restorative neurostimulation mechanism of action to address multifidus dysfunction caused by overloaded soft tissues, muscles, bones, and joints, aiming to restore muscle function gradually over time. Dr. Thomson emphasizes the therapy's success in both older and younger patient cohorts and highlights its advantages over traditional palliative back pain management methods. He also discusses the results of post-market clinical studies, which show similar benefits for both younger and older patient populations and a positive long-term impact.  This episode is a must-listen for all those seeking effective alternative solutions for chronic mechanical low-back pain who might benefit from the transformative potential of ReActiv8 therapy. Resources:  Check more episodes of this Thought Leadership Series here. Watch the entire interview here. Connect and follow Simon Thomson on LinkedIn and X. Visit Simon Thomson's website and email him here. Listen to a previous Outcomes Rocket episode about ReActiv8 here. Read Simon Thomson's insightful paper on restorative neurostimulation for chronic mechanical low back pain here.

Around 80% of adults experience low back pain, and most are not candidates for surgery. Prentiss Lawson, Jr., M.D., and Christopher Paul, M.D., both anesthesiologists who specialize in pain medicine, discuss a promising new durable therapy for low back pain called restorative neurostimulation. Unlike existing low back pain management options, neurostimulation addresses a root cause, a weak or inactive multifidus muscle. The doctors explain the minimally invasive procedure, which involves sending electric pulses to the multifidus nerves. Learn how this treatment uniquely restores patents' spinal stability and thereby reduces chronic pain.

How can we use innovations in neuroengineering and AI to alleviate nerve pain and discomfort experienced by millions of people with diabetes? What can we do to reduce their risk of falls and improve their quality of life? Join us on an insightful journey into neuroengineering, healthcare innovation, and entrepreneurship in this episode of "Neurocareers: Doing the Impossible!" We'll explore the challenges faced by those living with diabetic neuropathy and the urgent need for effective solutions to enhance their quality of life. Imagine a groundbreaking device that harnesses the power of artificial intelligence and neurostimulation to relieve those suffering from diabetic neuropathic pain. That's precisely what MYNERVA, a pioneering startup co-founded by Dr. Greta Preatoni, is working tirelessly to develop. Dr. Preatoni, a neuroengineering Ph.D. graduate from ETH Zürich, is at the forefront of this transformative endeavor. Her passion for applying cutting-edge research to real-world problems has led her to spearhead the development of a revolutionary device to restore sensation and reduce pain via non-invasive nerve stimulation. In this episode, Dr. Preatoni will share her inspirational academic and entrepreneurial journey, offering valuable insights into the intersection of neuroscience, technology, and healthcare. Her story is a testament to determination and innovation. It also serves as a beacon of inspiration for women considering careers in neuroscience and neurotechnologies. Tune in to "Neurocareers: Doing the Impossible!" and discover the remarkable potential of AI-driven neurostimulation in transforming the lives of individuals affected by diabetic neuropathy. Use this opportunity to learn from Dr. Greta Preatoni's pioneering work and her vision for a brighter, pain-free future for millions worldwide. About the Podcast Guest: Dr. Greta Preatoni is the CEO & Co-founder of MYNERVA, an ETH spin-off developing a AI-driven neurostimulating device to restore touch and reduce pain in diabetic neuropathy. Dr. Preatoni completed her PhD in Neuroengineering at ETH Zurich, where the idea of MYNERVA was born and tested in several clinical trials with great success. Her passion is rooted between the interconnection of the mind, the body and technologies, and MYNERVA is the culmination of this passion.  Connect with Greta via LinkedIn: https://www.linkedin.com/in/greta-preatoni-7aabb3151/ Learn about MYNERVA: https://www.linkedin.com/company/mynervamedical/ About the Podcast Host: The Neurocareers podcast is brought to you by The Institute of Neuroapproaches (https://www.neuroapproaches.org/) and its founder, Milena Korostenskaja, Ph.D. (Dr. K), a neuroscience educator, research consultant, and career coach for people in neuroscience and neurotechnologies. As a professional coach with a background in the field, Dr. K understands the unique challenges and opportunities job applicants face in this field and can provide personalized coaching and support to help you succeed. Here's what you'll get with one-on-one coaching sessions from Dr. K: Identification and pursuit of career goals Guidance on job search strategies, resume and cover letter development, and interview preparation Access to a network of professionals in the field of neuroscience and neurotechnologies Ongoing support and guidance to help you stay on track and achieve your goals You can always schedule a free neurocareer consultation/coaching session with Dr. K at https://neuroapproaches.as.me/free-neurocareer-consultation Subscribe to our Nerocareers Newsletter to stay on top of all our cool neurocareers news at updates https://www.neuroapproaches.org/neurocareers-news

Unlike traditional pain management, ReActiv8 therapy uniquely addresses chronic low back pain by restoring neuromuscular control and functional spine stability. In this episode, Dr. Chris Gilligan, MD, MBA, Executive Medical Director, Mass General Brigham Global Advisory, Senior Medical Director of Periprocedural Services, Director of Brigham and Women's Spine Service Line, Chief - Division of Pain Medicine, Brigham and Women's Hospital, discusses the groundbreaking five-year data on ReActiv8 therapy for chronic low back pain, offering insights into this transformative approach and its impact on patients' lives. Chris delves into the significant findings from his research, shedding light on the ReActiv8 therapy's effectiveness in addressing chronic low back pain and improving patients' quality of life. He provides an in-depth overview of the research, covering the methodology, patient demographics, and the remarkable outcomes achieved over the five-year study period. Dr. Gilligan also addresses the implications of the findings for payers, providers, and patients, offering a holistic perspective on the therapy's clinical and economic significance. Join Chris and Saul as they uncover the remarkable impact of this novel therapy and explore its broader implications for patients, physicians, and payers in the healthcare ecosystem. Resources:  Watch this amazing interview here. Connect with and follow Chris Gilligan on LinkedIn here. Learn more about ReActiv8-B Trial 3-Year Patient Outcomes Data here. Listen to Dr. Chris's previous interview. Visit the Mainstay website here.

MedLink Neurology Podcast is delighted to feature selected episodes from BrainWaves, courtesy of James E Siegler MD, its originator and host. BrainWaves is an academic audio podcast whose mission is to educate medical providers through clinical cases and topical reviews in neurology, medicine, and the humanities, and episodes originally aired from 2016 to 2021. Originally released: November 30, 2017 Last week was all about how destroying bad brain can help patients with epilepsy. This week, in a stimulating discussion with Dr. Becker, we're reviewing the ways we can activate the nervous system in order to prevent future seizures: the vagus nerve stimulator, deep brain stimulation, and the responsive neurostimulation system. Produced by James E Siegler. Music by Chris Zabriskie, Josh Woodward, and Kevin McLeod. Voiceover by Erika Mejia. BrainWaves' podcasts and online content are intended for medical education only and should not be used for clinical decision-making. REFERENCES A randomized controlled trial of chronic vagus nerve stimulation for treatment of medically intractable seizures. The Vagus Nerve Stimulation Study Group. Neurology 1995;45(2):224-30. PMID 7854516Ben-Menachem E. Vagus-nerve stimulation for the treatment of epilepsy. Lancet Neurol 2002;1(8):477-82. PMID 12849332DeGiorgio CM, Krahl SE. Neurostimulation for drug-resistant epilepsy. Continuum (Minneap Minn) 2013;19(3 Epilepsy):743-55. PMID 23739108Fisher R, Salanova V, Witt T, et al. Electrical stimulation of the anterior nucleus of thalamus for treatment of refractory epilepsy. Epilepsia 2010;51(5):899-908. PMID 20331461Handforth A, DeGiorgio CM, Schachter SC, et al. Vagus nerve stimulation therapy for partial-onset seizures: a randomized active-control trial. Neurology 1998;51(1):48-55. PMID 9674777Lanska DJ. JL Corning and vagal nerve stimulation for seizures in the 1880s. Neurology 2002;58(3):452-9. PMID 11839848Morrell MJ; RNS System in Epilepsy Study Group. Responsive cortical stimulation for the treatment of medically intractable partial epilepsy. Neurology 2011;77(13):1295-304. PMID 21917777Morris GL 3rd, Gloss D, Buchhalter J, Mack KJ, Nickels K, Harden C. Evidence-based guideline update: vagus nerve stimulation for the treatment of epilepsy: report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology 2013;81(16):1453-9. PMID 23986299Penry JK, Dean JC. Prevention of intractable partial seizures by intermittent vagal stimulation in humans: preliminary results. Epilepsia 1990;31 Suppl 2:S40-3. PMID 2121469Yuan H, Silberstein SD. Vagus nerve and vagus nerve stimulation, a comprehensive review: Part II. Headache 2016;56(2):259-66. PMID 26381725  We believe that the principles expressed or implied in the podcast remain valid, but certain details may be superseded by evolving knowledge since the episode's original release date.

Are you an engineering student contemplating the value of pursuing a PhD? Wondering how your research could lead to meaningful entrepreneurial ventures? Tune in to our valuable conversation with Sam Darvishi, PhD, a visionary entrepreneur who used his PhD thesis in motor imagery-based Brain-Computer Interfaces (BCIs) as a stepping stone to create a profound impact on thousands of people worldwide suffering from the consequences of stroke. In this episode of 'Neurocareers: Doing the Impossible!', we explore the fascinating journey of Sam Darvishi, the Founder and CEO of RehabSwift, a pioneering medical device company that's revolutionizing neuro-rehabilitation. Imagine a future where neuro-rehabilitation isn't a one-size-fits-all approach but a highly personalized journey. This is the reality of groundbreaking neurotech innovations in healthcare, and RehabSwift is at the forefront. RehabSwift's advanced neuro-rehabilitation interface is clinically proven to enhance hand and arm mobility, dexterity, strength, and sensation in stroke survivors. But what truly sets it apart is its ability to tailor rehabilitation to each individual's unique timing pattern. This means harnessing the incredible power of the mind to significantly boost rehabilitation outcomes. It's not just a game-changer; it's a life-changer. Join us as we delve into Sam's remarkable journey, from his academic roots to becoming a trailblazer in personalized neuro-rehabilitation. Discover how he leveraged his PhD research to establish RehabSwift, offering individualized BCI-driven upper limb rehabilitation after stroke. We'll also discuss the skills and qualities essential for aspiring professionals in the neurotech industry. Get ready to be inspired and informed! Tune in to 'Neurocareers: Doing the Impossible!' and learn how individuals like Sam Darvishi are reshaping the future of healthcare and neuroscience while making a profound impact on the world. About the Podcast Guest: Dr. Sam Darvishi is a dynamic force at the intersection of neuroscience, engineering, and entrepreneurship. As the Founder and CEO of RehabSwift, he's on a mission to redefine neuro-rehabilitation through cutting-edge brain-computer interfaces (BCIs) designed to fast-track hand movement recovery for stroke patients. Dr. Darvishi's academic journey includes a Doctor of Philosophy in Neural Engineering from the University of Adelaide and a Master of Engineering in Automation and Manufacturing from the University of Sydney, where he achieved a degree with Merit and conducted groundbreaking research in motor imagery pattern classification. At RehabSwift, Sam combines advanced technology with evidence-based neuroscience principles, crafting highly personalized and effective rehabilitation solutions. His pioneering work is poised to transform the lives of stroke survivors globally. By breaking barriers in stroke recovery, he empowers individuals to regain independence, leaving an indelible mark on countless lives. Sam aims to position RehabSwift as a global leader in neuro-rehabilitation, making a lasting impact on the field and the lives it touches. Connect with Dr. Darvishi to explore his innovative work and the transformative potential of RehabSwift's groundbreaking solutions: Via e-mail: sam@rehabswift.com Via LinkedIn: https://www.linkedin.com/in/sam-darvishi/ Learn about RehabSwift here: https://rehabswift.com.au/ About the Podcast Host: The Neurocareers podcast is brought to you by The Institute of Neuroapproaches (https://www.neuroapproaches.org/) and its founder, Milena Korostenskaja, Ph.D. (Dr. K), a neuroscience educator, research consultant, and career coach for students and recent graduates in neuroscience and neurotechnologies. As a professional coach with a background in the field, Dr. K understands the unique challenges and opportunities facing students in this field and can provide personalized coaching and support to help you succeed. Here's what you'll get with one-on-one coaching sessions from Dr. K: Identification and pursuit of career goals Guidance on job search strategies, resume and cover letter development, and interview preparation Access to a network of professionals in the field of neuroscience and neurotechnologies Ongoing support and guidance to help you stay on track and achieve your goals You can always schedule a free neurocareer consultation/coaching session with Dr. K at https://neuroapproaches.as.me/free-neurocareer-consultation Subscribe to our Nerocareers Newsletter to stay on top of all our cool neurocareers news at updates https://www.neuroapproaches.org/neurocareers-news  

Have you ever wondered what it takes to transform brain science into groundbreaking products and services? Are you curious about the fearless visionaries who bridge the gap between neuroscience and entrepreneurship to change people's lives and reshape our world? Are you ready to explore how to navigate the uncharted waters of neurotech entrepreneurship? In Season 2 of the "Neurocareers: Doing the Impossible!" podcast, we're diving deep into the world of entrepreneurial ventures in neuroscience and neurotechnologies. If you're looking to create an immediate impact and translate your neuroscience and neurotech ideas into innovative services that truly make a difference in the world, this season is tailor-made for you. Join us and learn from the best in the field about succeeding in the entrepreneurial journey in neuroscience and neurotechnology, where innovation meets impact. Today, we're embarking on a journey into the realm of tranquility and innovation. Have you ever wondered how we can achieve a calm state in our chaotic world? What if I told you that technology, particularly ultrasound, holds the key to unlocking that serene oasis within ourselves? In our quest for answers, we've invited a true pioneer, someone who's pushing the boundaries of what's possible when it comes to achieving inner peace and well-being. Jonathan Hacker, the founder of NeurGear, joins us today to delve into the fascinating world of neurotechnology and ultrasound's role in the pursuit of calmness. Jon uses ultrasound technology to create innovative neurostimulation devices that help people find calm. Jon embodies the spirit of a young entrepreneur who dreams and takes bold steps to turn those dreams into reality. Jonathan's journey from a curious young mind to a leading neurotechnologist and entrepreneur is remarkable. Jonathan wears many hats – from being a student to being a neurotechnologist, researcher, and entrepreneur. His journey into neuroscience began at the tender age of 12, fueled by curiosity. Imagine diving headfirst into scholarly articles, driven by a passion that would lead him to the heart of the Neurotech industry. Fast-forward to 2020, and Jonathan's story takes an exciting twist. After graduating from high school and joining the Rochester Institute of Technology (RIT), he refused to let the challenges posed by the pandemic dampen his spirit. In fact, he used them as stepping stones, leveraging RIT's resources and connections to accelerate his research progress. Thus, the foundation was laid for NeurGear, an early-stage neurostimulation company pioneering ultrasound technology.  Tune in to this electrifying episode as we explore Jonathan's remarkable journey from a young prodigy fascinated by neuroscience to driving innovation in the Neurotech industry. Get ready to be inspired, informed, and empowered by the boundless possibilities of neurotechnology as we sit down with Jonathan Hacker. This episode promises insights, passion, and a glimpse into the future of neuroinnovation! About the podcast guest: Jonathan's academic journey is as impressive as it is diverse. He is a dual major in Biomedical Engineering (BME) and the School Of Individualized Study (SOIS) at the prestigious Rochester Institute of Technology (RIT). His academic focus revolves around the fascinating realm of neurotechnology, where he combines his engineering prowess with a deep understanding of individualized study. Jonathan's fascination with the field started at the tender age of 12, setting him on a path of relentless curiosity and dedication. For close to eight years, he has been preparing, researching, and planning for what NeurGear represents today—a cutting-edge neurostimulation company on the cusp of transforming the industry. Jonathan's expertise extends beyond the confines of traditional research. As NeurGear's CEO, he has ventured into business and management, honing his skills to lead his team and prepare for the company's launch. Yet, his commitment to research remains unwavering, ensuring innovation remains at the heart of NeurGear's mission. Outside of his entrepreneurial pursuits, Jonathan finds solace in the world of manga and gaming, indulging in his other passions when time allows. However, his dedication to NeurGear's vision truly defines him. Connect with Jonathan on LinkedIn: https://www.linkedin.com/in/jon-hacker/ Learn about NeuroGear: https://www.neurgear.com/ and its product ZenBud Ultrasound Vagus Verve Stimulator: https://zenbud.health/ Listen to Jonathan's podcast: https://open.spotify.com/show/0jRohAftpqdbgp3wByPFhB   About the podcast host: The Neurocareers podcast is brought to you by The Institute of Neuroapproaches (https://www.neuroapproaches.org/) and its founder, Milena Korostenskaja, Ph.D. (Dr. K), a neuroscience educator, research consultant, and career coach for students and recent graduates in neuroscience and neurotechnologies. As a professional coach with a background in the field, Dr. K understands the unique challenges and opportunities facing students in this field and can provide personalized coaching and support to help you succeed. Here's what you'll get with one-on-one coaching sessions from Dr. K: Identification and pursuit of career goals Guidance on job search strategies, resume and cover letter development, and interview preparation Access to a network of professionals in the field of neuroscience and neurotechnologies Ongoing support and guidance to help you stay on track and achieve your goals You can always schedule a free neurocareer consultation/coaching session with Dr. K at https://neuroapproaches.as.me/free-neurocareer-consultation Subscribe to our Nerocareers Newsletter to stay on top of all our cool neurocareers news at updates https://www.neuroapproaches.org/neurocareers-news  

Paul Meadows is one of the founding members of IFESS and a  veteran in the neurotech industry. He is currently the Chief Technology Officer at Imthera in the development of neurostimulation device for obstructive sleep apnea. The company was recently acquired by LivaNova. Previous Meadows was involved with neurotech development at Advanced Bionics as well as the Alfred E. Mann Foundation. Takeaways: 1. Current technology transfer developments are influenced by peer-reviewed published research. 2. Learn from the past so we don't repeat in the future, applies to neurotech applications. 3. We still have technology challenges in such areas as cybersecurity and battery technology as well as systemic in clinical technology adoption. [0:00] Ladan introduces the episode and joins the conversation with Paul Meadows and Jen French. [1:02] Paul Meadows describes his involvement and various positions with IFESS since the inception of the organization. [1:46] Discussion of his view of the evolution of IFESS over the years. [2:35] Meadows describes the importance of peer-reviewed publications and the need to review past research. [3:43] There are obstacles for technology adoption such as clinical physical therapist curriculum. [3:58] Meadow's outlook for exciting developments in the next 5 years in miniaturization, packaging and user-friendly interfaces. This is accompanied by identified risks such as cybersecurity. [5:52] Identifying that there is some basic science that is limiting technology advancements such as battery technology.

In this episode of BackTable Urology, Dr. Jose Silva and Dr. Suzette Sutherland, director of Female Urology at Northwestern university, discuss new therapies for overactive bladder (OAB). --- CHECK OUT OUR SPONSOR Wellprept https://wellprept.com/ --- EARN CME Reflect on how this Podcast applies to your day-to-day and earn free AMA PRA Category 1 CMEs: https://earnc.me/V7Flno --- SHOW NOTES First, they describe the symptoms of OAB which include an increased frequency and urgency of urination, sometimes leading to urinary incontinence. Conservative measures include pelvic floor exercises, diet, and lifestyle changes. If patients fail conservative measures, urologists can prescribe anticholinergics. However,beta agonists are preferable because they do not cross the blood-brain barrier. Then. the doctors briefly chat about the use of these agents in Alzheimer disease patients as well, which may be dependent on insurance approval. Next, Dr. Sutherland summarizes surgical devices to treat OAB and the clinical trials supporting each of them. Sacral nerve neuromodulation is a device that has been on the market for years, but newer models that include fixed and rechargeable batteries are starting to become more available. Additionally, the Neuspera is a sacral nerve neuromodulation that operates wirelessly through Bluetooth. The doctors also compare the two existing models of sacral neuromodulation (Medtronic vs. Axonics). One newer surgical treatment is tibial nerve stimulation, and Dr. Sutherland summarizes her placement technique, voltage settings, intraoperative testing, and the importance of a healthy ankle evaluation prior to placing the device. promising results, in-office, sedation, healthy ankle evaluation. She also notes that repositioning the leads in sacral and tibial neuromodulation in a followup visit may be necessary. Finally, she shares about Fempulse, vaginal stimulator mimicking a pessary, that is still being tested in research trials. --- RESOURCES Wellprept ​​https://wellprept.com/

Hello everyone and welcome back to the Criminal Justice Evolution Podcast. A Top Ranked show because of you. Thank you so much. If you are a long time listener welcome back. If you are a new listener - Welcome to the show! A special thanks to all the brave men and women who serve in the First Responder World. Thank you for what you do on a daily basis. Remember you are honored, cherished and loved. Keep up the great work. I struggled. I was in a dark place for a long time. I was in pain, and I masked it with alcohol.  I was contemplating hurting myself.  I finally decided to reach out and ask for help, and I am grateful I did. FHE Health and The Shatterproof Program saved my life. If you are struggling, you don't have to stay there. We can and will help you. Reach out today at 303.960.9819. https://www.cjevolution.com/shatterproof/ So excited to have a guest on the show who has several years of law enforcement experience and who is now a clinician helping first responders. Rebecca Allanson stopped by the podcast. She served 18 years as a police officer in Australia and The United States. She then pivoted and became a clinician.  She is a sought after speaker and presenter and she is the Director of Health and Wellness for The Badge Group and The Colorado Fraternal Order of Police.  In this episode Rebecca and I talk about wellness among first responders and she talks about some of the treatment modalities she employs such as EMDR and Neurostimulation. Rebecca also opened up and shared some of her struggles. She also gives great advice to the listeners who are struggling.  A great and informative show.  You can find Rebecca here: https://www.coloradofop.org/  https://www.linkedin.com/in/rebecca-allanson-99468998/    Fraternal Order of Police Las Vegas Convention: https://fop.net/news-and-events/2023-biennial-national-conference-expo/    Stay tuned for more great episodes: www.cjevolution.com   Patrick

How do you get started on a brain health program? Join Dr. Jeffrey Gladden and Guy Odishaw in this episode of the Gladden Longevity Podcast. Guy Odishaw is a CTO, NFP, healthcare entrepreneur, bioelectric medicine practitioner, and founder of Bhakti Wellness Center, one of the country's largest, most diverse, integrative student health clinics at the University of Neuromodulation. Cofounder of Minnesota Bredesen Clinic - Dementia Prevention & Treatment Co-founder of CerebralFit Brain Training, a Nutraceutical, Electroceutical company. Guy's 30 years of clinical experience specializing in treatment-resistant chronic pain, traumatic brain injury and psycho-emotional trauma informs his approach to brain health. Additionally, his 20+ years as a meditation instructor and facilitator of courses on personal growth help him understand how to support clients through the potent changes arising from Neurotherapy. Brain training not only alleviates unwanted symptoms; but also, positively changes one's whole sense of self and relationship to the world around them. This episode discussed solutions for addressing cognitive decline and neurodegenerative conditions, bioelectric medicine for improving health and vitality, infrared light's effect on the brain and body, and the power of entrainment to restore brain function.   Listen to this episode to learn about making100 the new 30 and living young for a lifetime! -- REFERRAL: 
 
Get your CerebralFit here: http://www.awin1.com/cread.php?awinmid=47857&awinaffid=1319375  -- Dr. Gladden talks about the show and what it's about. (00:53)  Trained acupuncturist turns to Bioelectric Medicine. (03:49)  Guy shares how a practitioner invited him to watch her work. (5:02)  Electrical signals in the body; unexplored, limited potential. (08:54)  Physical and energetic processes, chemical and electrical levels. (11:21)  Dr. Gladden notes that Guy may be talking about intelligence at the cellular level. (13:50)  Guy speaks about gap junctions at the cellular level. (15:26)  The mouse model shows regrowth, memory not in the brain, consciousness in conversation. (18:37)  Guy details his progress over time. (21:45)  Dr. Gladden says to understand what was going on, he discovered they needed both the anatomy and physiology. (23:50)  QEG provides a detailed analysis of brain communication. (26:56)  Guy explains entrainment and what he thinks about it. (29:04)  Approach: Multisystem restoration and disease combat. (32:13) Guy mentions the use of audio-visual entrainment devices as part of their plan. (32:36)  Guy describes the glymphatic system as the detox for the brain. (34:55)  Doctors' knowledge is outdated, and the medical system is flawed. Electrical stimulation and audiovisual entrainment are explained. (38:20)  You are best n0t to use your doctor as a measure of progressive medicine. (40:08)  The mitochondria do a lot of cell signaling. (42:25)  The device is similar to a brain tap and has some important features. (45:08)  Neurostimulation can help improve brain function in dementia. (49:28)  Guy goes into detail about an MIT study. (50:25)  The autism spectrum is diverse; treatment varies. (53:05)  Dr. Gladden describes the headband that has been shown and lists what it does. (55:39)  Guy voices that wearables are great for people who are healthy. (58:13)  Dr. Gladden remarks about how fascinating the conversation has been. (1:00:37)  Dr. Gladden thanks Guy Odishaw. (1:03:37)               Visit our website, www.gladdenlongevitypodcast.com, for more information on this episode and other episodes as well. Click on the link to let us know what you'd like us to talk about on the podcast too!                            Follow us on social media!                                      Instagram: @gladdenlongevity                                      Twitter: @gladdenlongevit                                      Facebook: @GladdenLongevity                               LinkedIn: @GladdenLongevity     For more information on our practice or how to become a client, visit:   www.gladdenlongevity.com  Call us: 972-310-8916  Or email us: info@gladdenlongevity.com    To learn more about Guy, check out the following:   www.cerebralfit.com  IG: @cerebralfit

#HealingandGrowth #PersonalizedTreatment #NeuralPlasticity Click here to find out more and book: https://gettherapybirmingham.podbean....

In this week's podcast, Neurology Today's editor-in-chief discusses long-term adverse outcomes from pregnancy-associated stroke, a robotic device to assist shoulder movement in ALS, and the promise of neurostimulation for refractory seizures in the ICU.  

As a child, Micah would experience episodes where he would space out or become manic in class, leading his teachers to assume he had a mood disorder. He would have night terrors where his consciousness would expand beyond his body, believing he was connected to something otherworldly. He chalked it […]

Jan's journey with healing began with chronic physical issues that wouldn't resolve by means of modern medicine. Exploring alternatives led her to discover the connection between psychological stress and physiological issues and inspired her to become a psychotherapist.Beginning her practice in 1993, Jan was also the co-director of a Toronto school of Tai Chi Chuan from 1988 – 2018, where she taught hundreds of bodies how to live and move in a harmonious and integrated way. In 2005, Jan began her studies in Sensorimotor Psychotherapy, which offered a way to bring the richness of her somatic experience into the therapy space, leading to her specialty in trauma and dissociative disorders and the creation of WellSpace Trauma Therapy Clinic.Since 2018, Jan has been a Consultant for the Sensorimotor Psychotherapy Institute and the Clinical Director of WellSpace Trauma Therapy Clinic, offering Sensorimotor Psychotherapy, Neurofeedback, Neurostimulation and Group Therapy.In This EpisodeWellSpace websiteJan's email---What's new with The Trauma Therapist Project!The Trauma 5: gold nuggets from my 600+ interviewsThe Therapists Teach Workshop: a workshop for therapists who want to create their first online course.This show is part of the Spreaker Prime Network, if you are interested in advertising on this podcast, contact us at https://www.spreaker.com/show/5739761/advertisement

Neurostimulation is advancing in exciting ways. One such innovation is called high frequency spinal cord stimulation which does not cause a tingling sensation. In fact, it just replaces the pain, with pain relief. Studies suggest that it may better control chronic low back pain too. Robin describes how this new spinal cord stimulator changed her […]

Neurostimulation is advancing in exciting ways. One such innovation is called high frequency spinal cord stimulation which does not cause a tingling sensation. In fact, it just replaces the pain, with pain relief. Studies suggest that it may better control chronic low back pain too. Robin describes how this new spinal cord stimulator changed her […]

Neurostimulation is advancing in exciting ways. One such innovation is called high frequency spinal cord stimulation which does not cause a tingling sensation. In fact, it just replaces the pain, with pain relief. Studies suggest that it may better control chronic low back pain too. Robin describes how this new spinal cord stimulator changed her […]

Neurostimulation is advancing in exciting ways. One such innovation is called high frequency spinal cord stimulation which does not cause a tingling sensation. In fact, it just replaces the pain, with pain relief. Studies suggest that it may better control chronic low back pain too. Robin describes how this new spinal cord stimulator changed her […]

Meredith Langhorst, a specialist in spinal diagnostics and therapeutics, and her patient Eric Osborn, a veteran of the US Navy, talk about the Reactiv8 therapy and how its restorative neurostimulation approach has helped patients reduce their lower back pain without the need for surgery.   Click this link to the show notes, transcript, and resources: outcomesrocket.health

Joining Jonathan to discuss how the skills needed to perform laparoscopic keyhole surgery as well as e-sports can be significantly enhanced by applying electric neurostimulation during training is Adam Toth, ESRL Research Program Manager at Lero in the University of Limerick.

Huberman Lab Podcast Notes Key Takeaways Evolution of psychiatry: phase I – must be something genetic or how you were raised; phase II – must be a chemical imbalance or something chemically missingThere's actually a decrease in the level of activity in the brain on psychedelics, but the connectivity in regions increasesWe're all taught to retain some level of control in our day-to-day lives – part of the therapeutic effect of psychedelics is about untethering, letting go, and letting the system assume a natural state you've been fightingMental health disorders exist on a range; you may not reach a clinical level of OCD but you may have some tendencies or habits“If you can rid yourself of all to social and cultural constructions and re-examine these if we just discovered these today, we'd say that [psychedelics] are a huge breakthrough in psychiatry.” – Dr. Nolan WilliamsPsychedelics allow you to enter into a highly plastic state and reconsolidate memory which may drive a therapeutic effectAnti-psychotic therapeutic effects of cannabis are from the CBD and not the THC – the problem is we have potent strains now heavy with THC and low in CBDTranscranial magnetic stimulation (TMS) has the potential to send a signal to the prefrontal cortex and use the brain's own communication style to get it out of a depressive state – you're tapping into core circuitry with minimal side effects (unlike tinkering neurotransmitters)Read the full notes @ podcastnotes.orgIn this episode, my guest is Nolan Williams, M.D., a triple board-certified psychiatrist, neurologist and professor of psychiatry and behavioral sciences at Stanford School of Medicine. He is also the Director of the Stanford Brain Stimulation Lab. We discuss clinical applications for brain stimulation, behavioral protocols and novel drug treatments to halt and reverse mental health disorders, including depression and post-traumatic stress disorder (PTSD). We first discuss the neural circuits for self-identity and mood and stress control. We discuss Dr. Williams' work using transcranial magnetic stimulation (TMS) to depression, trauma, PTSD, and other mood disorders. We then dive deep into the history, biology, modern use, and safety margins of the various psychedelics, including MDMA, LSD, ketamine, ibogaine, ayahuasca, and psilocybin, as well as cannabis and the use of SSRIs in both adults and children. Finally, we discuss behavioral treatments for mental health disorders, including sleep and sleep deprivation, light exposure, exercise, and training to control the brain-heart-rate pathways. Regardless of age, all those interested in mental health should benefit from the incredible breadth and depth of Dr. Williams' knowledge and the clarity with which he conveys that information. Thank you to our sponsors AG1 (Athletic Greens): https://athleticgreens.com/huberman InsideTracker: https://insidetracker.com/huberman Eight Sleep: https://www.eightsleep.com/huberman ROKA: https://www.roka.com/huberman Supplements from Momentous https://www.livemomentous.com/huberman Huberman Lab Premium https://hubermanlab.com/premium For the full show notes, visit hubermanlab.com Timestamps (00:00:00) Dr. Nolan Williams, Brain Stimulation & Depression Treatment (00:03:31) Huberman Lab Premium (00:04:42) InsideTracker, Eight Sleep, ROKA (00:08:37) Momentous Supplements (00:09:16) Depression, Risk Factors, Emergency Psychiatric Treatments (00:15:11) The Brain-Heart Connection, Vagus Nerve, Prefrontal Cortex (00:17:51) Right vs. Left Brain Hemispheres & Mood Balance, Connectome (00:22:34) Heart Rate & Depression, Behavioral Interventions, Transcranial Magnetic Stimulation (TMS) (00:33:02) Prefrontal Cortex & Cognitive Control, TMS (00:37:46) AG1 (Athletic Greens) (00:39:00) Belief/Identity “Rules”, Re-scripting, TMS & Talk Therapy (00:45:49) Dorsolateral Prefrontal Cortex, TMS & Depression Treatment (00:48:36) Cingulate Cortex & Emotion, Dissociation & Catatonia (00:54:27) Ketamine, the Opioid System & Depression; Psychedelic Experience or Biology? (01:03:42) SSRIs, Serotonin & Depression; Childhood, Chemical Imbalance or Circuit? (01:13:58) Memories & “Rule” Creation; Psilocybin & “Rule” Resolution (01:21:00) MDMA & Post-Traumatic Stress Disorder (PTSD) Treatment, Psilocybin & Depression Treatment (01:24:12) Is MDMA Neurotoxic?, Drug Purity, Dopamine Surges, Post-MDMA Prolactin (01:30:38) Psilocybin, Brain Connectivity & Depression Treatment (01:34:53) Exposure Response Prevention: “Letting Go” & Depression Treatment (01:41:23) Normal Spectrums for Mental Health Disorders (01:45:35) Ibogaine & “Life Review”; PTSD, Depression & Clinical Trials (01:57:16) Clinical Use of Psychedelics (02:01:59) Ayahuasca, Brazilian Prisoner Study (02:06:55) Cannabis: THC, CBD & Psychosis, Clinical Uses (02:14:52) Personal Relative Drug Risk & Alcohol (02:20:42) Circadian Reset for Depression, Sleep Deprivation, Light (02:28:43) Stanford Neuromodulation Therapy (SNT) Study (02:34:25) Space Learning Theory & TMS Stimulation (02:45:35) Zero-Cost Support, YouTube Feedback, Spotify & Apple Reviews, Sponsors, Huberman Lab Premium, Neural Network Newsletter, Social Media Title Card Photo Credit: Mike Blabac Disclaimer

In this episode, my guest is Nolan Williams, M.D., a triple board-certified psychiatrist, neurologist and professor of psychiatry and behavioral sciences at Stanford School of Medicine. He is also the Director of the Stanford Brain Stimulation Lab. We discuss clinical applications for brain stimulation, behavioral protocols and novel drug treatments to halt and reverse mental health disorders, including depression and post-traumatic stress disorder (PTSD). We first discuss the neural circuits for self-identity and mood and stress control. We discuss Dr. Williams' work using transcranial magnetic stimulation (TMS) to depression, trauma, PTSD, and other mood disorders. We then dive deep into the history, biology, modern use, and safety margins of the various psychedelics, including MDMA, LSD, ketamine, ibogaine, ayahuasca, and psilocybin, as well as cannabis and the use of SSRIs in both adults and children. Finally, we discuss behavioral treatments for mental health disorders, including sleep and sleep deprivation, light exposure, exercise, and training to control the brain-heart-rate pathways. Regardless of age, all those interested in mental health should benefit from the incredible breadth and depth of Dr. Williams' knowledge and the clarity with which he conveys that information. Thank you to our sponsors AG1 (Athletic Greens): https://athleticgreens.com/huberman InsideTracker: https://insidetracker.com/huberman Eight Sleep: https://www.eightsleep.com/huberman ROKA: https://www.roka.com/huberman Supplements from Momentous https://www.livemomentous.com/huberman Huberman Lab Premium https://hubermanlab.com/premium For the full show notes, visit hubermanlab.com Timestamps (00:00:00) Dr. Nolan Williams, Brain Stimulation & Depression Treatment (00:03:31) Huberman Lab Premium (00:04:42) InsideTracker, Eight Sleep, ROKA (00:08:37) Momentous Supplements (00:09:16) Depression, Risk Factors, Emergency Psychiatric Treatments (00:15:11) The Brain-Heart Connection, Vagus Nerve, Prefrontal Cortex (00:17:51) Right vs. Left Brain Hemispheres & Mood Balance, Connectome (00:22:34) Heart Rate & Depression, Behavioral Interventions, Transcranial Magnetic Stimulation (TMS) (00:33:02) Prefrontal Cortex & Cognitive Control, TMS (00:37:46) AG1 (Athletic Greens) (00:39:00) Belief/Identity “Rules”, Re-scripting, TMS & Talk Therapy (00:45:49) Dorsolateral Prefrontal Cortex, TMS & Depression Treatment (00:48:36) Cingulate Cortex & Emotion, Dissociation & Catatonia (00:54:27) Ketamine, the Opioid System & Depression; Psychedelic Experience or Biology? (01:03:42) SSRIs, Serotonin & Depression; Childhood, Chemical Imbalance or Circuit? (01:13:58) Memories & “Rule” Creation; Psilocybin & “Rule” Resolution (01:21:00) MDMA & Post-Traumatic Stress Disorder (PTSD) Treatment, Psilocybin & Depression Treatment (01:24:12) Is MDMA Neurotoxic?, Drug Purity, Dopamine Surges, Post-MDMA Prolactin (01:30:38) Psilocybin, Brain Connectivity & Depression Treatment (01:34:53) Exposure Response Prevention: “Letting Go” & Depression Treatment (01:41:23) Normal Spectrums for Mental Health Disorders (01:45:35) Ibogaine & “Life Review”; PTSD, Depression & Clinical Trials (01:57:16) Clinical Use of Psychedelics (02:01:59) Ayahuasca, Brazilian Prisoner Study (02:06:55) Cannabis: THC, CBD & Psychosis, Clinical Uses (02:14:52) Personal Relative Drug Risk & Alcohol (02:20:42) Circadian Reset for Depression, Sleep Deprivation, Light (02:28:43) Stanford Neuromodulation Therapy (SNT) Study (02:34:25) Space Learning Theory & TMS Stimulation (02:45:35) Zero-Cost Support, YouTube Feedback, Spotify & Apple Reviews, Sponsors, Huberman Lab Premium, Neural Network Newsletter, Social Media Title Card Photo Credit: Mike Blabac Disclaimer

Exciting things are happening when it comes to back pain treatment! In this episode, Dr. Chris Gilligan, Chief Medical Officer of the Division of Pain Medicine, Department of Anesthesiology, Perioperative, and Pain Medicine at Brigham and Women's Hospital, speaks about new developments and therapies for the treatment of chronic low back pain. He explains how patients' back pain is evaluated and categorized before treatment and the usual procedure based on that classification. He discusses different types of solutions, including a new restorative neurostimulation therapy that's proving to have substantial clinical improvements. He's found himself surprised at the outcomes it has brought for all different sorts of patients, including those with scoliosis and/or spondylolisthesis with zero lead migrations. Dr. Gilligan also talks about the long-term benefits for patients' pain relief and economic savings. Tune in to this episode to learn about what Dr. Chris Gilligan has to share on exciting new developments that will help many patients who suffer from chronic back pain! Click this link to the show notes, transcript, and resources: outcomesrocket.health

Creating a different approach to helping patients with back pain is a daunting task, but ReActiv8 is doing it with flying colors. In this episode, we hear from Jason Hannon, executive director, and CEO at Mainstay Medical, about ReActiv8, a new groundbreaking therapy approach to help patients with back pain; This is the first back pain therapy focused on the cause and not just on its symptoms. Jason explains how ReActiv8 works through neural stimulation with the patient's participation to activate the muscle-generating stability in the spine. He discusses the results of a three-year study that show significant improvement for the patients who participated, an exciting outcome for back pain treatment. He also speaks of the challenges that come with entering the market after being so research-driven while being excited about what this type of therapy could represent for chronic pain management. Tune in to this episode to learn how ReActiv8 could be a paradigm shift for back pain treatment!

Toby Passman isn't your typical 20-something.  When his anxiety interrupted conversations and relationships, he began to apply the research he'd been doing in school to himself, using neurostimulation to retrain his brain. He saw the difference almost immediately. He went to work later at an EEG lab and started data collection with an eye toward helping improve the brain function of those impacted by some mental health conditions.  You will learn:* There are different ways to address anxiety and depression besides medication.* Neurostimulation is a painless way to stimulate different parts of the brain, and may provide positive effects earlier than traditional means.* Some practioners can provide virtual neurofeedack.For show notes, click HERE.

Here are the things to expect in this episode:What are the main neurotechnologies he works with?Training the brain to rewire itself through the help of these neurotechnologies. How does it feel to undergo a neurostimulation session?What other benefits does neurostimulation have?The value of following up sessions with a good diet and exercise.Is there anyone where neurostimulation may not be appropriate?And many more!About Toby Pasman:Toby Pasman is the founder of Roscoe's Wetsuit Neuro and host of the Roscoe's Wetsuit Neuro Podcast. He is a neurophysiology researcher with a Master's of Psychology from Lynn University and is board-certified in QEEG Brain Mapping and EEG Neurofeedback. Toby enjoys paddle boarding along the intracoastal, biking through the surrounding islands of Miami, and engaging in deep, intellectual conversations.Connect with Toby!Website: https://roscoeswetsuitneuro.com/ (Includes newsletter and link to free 15 min coaching session)  Discount code for PHAS listeners: https://roscoeswetsuitneuro.com/passionatehealthadvocateConnect with Denise DeShetler!Website: https://www.passionatehealthadvocate.com/Facebook: https://www.facebook.com/groups/phapodcastjunkiesLinkedIn: https://www.linkedin.com/in/denisedeshetlerInstagram:  https://www.instagram.com/passionatehealthadvocate/

Kelly Roman has been with Fisher Wallace since 2009.  Prior to him founding the company with Charles Fisher, Mr. Roman had graduated from Harvard and had been an award-winning executive in both the digital advertising and software-as-a-service industries.   While at Fisher Wallace, Kelly has been heading the program with their neurostimulation mental-health device.  This device uses low-level electrical impulses to stimulate certain areas of the brain.  This is meant to treat anxiety, depression, PTSD, sleep issues, as well as many other cognitive issues.  It also has been shown to increase focus and memory capabilities.    Kelly Roman, as well as Fisher Wallace as a whole, are dedicated to helping people acquire mental health care that doesn't include talk therapy or taking medication.  For more information on this device, you can check it out at fisherwallace.com.